Abstract
Shigella flexneri is a Gram-negative bacillus that is responsible for a severe form of dysentery called Shigellosis, which mainly affects children and the elderly in both underdeveloped and developed countries. Pathogenic S. flexneri strains possess a large virulence plasmid that codes for effector proteins that are required for the entry and spread of the bacteria into colonocytes. Among these proteins is the translocator IpaC, which plays an important role in the invasion process; IpaC is implicated in pore formation in the host cell membrane and induces cytoskeletal rearrangements in macrophages and epithelial cells, thereby promoting bacterial entry. The ability of IpaC to insert into the plasma membrane is due to a large nonpolar region of the protein structure. This characteristic also renders difficulties in recovery and purification when the protein is expressed in E. coli. Several works have considered different methodologies for the improved production and purification of IpaC. Herein, we propose an alternative method that is based on changes in the induction temperature and extraction buffer to facilitate the accumulation of high yields of soluble proteins for their further processing and ultimate use in biotechnological approaches.
Keywords: Shigella flexneri, IpaC production, purification, shigellosis, vaccines
Protein & Peptide Letters
Title:Cloning and Purification of IpaC Antigen from Shigella flexneri: Proposal of a New Methodology
Volume: 20 Issue: 2
Author(s): Cristiane Mobilon, Marcelo Augusto Szymanski de Toledo, Fernanda Laroza Paganelli, Clelton Aparecido dos Santos, Fernanda de Pace, Jacqueline Boldrin de Paiva, Eliana Guedes Stehling, Gerson Nakazato, Aline Gambaro Balieiro, Flavia Pereira da Silva Airoldi, Francisco de Assis Machado Reis and Wanderley Dias da Silveira
Affiliation:
Keywords: Shigella flexneri, IpaC production, purification, shigellosis, vaccines
Abstract: Shigella flexneri is a Gram-negative bacillus that is responsible for a severe form of dysentery called Shigellosis, which mainly affects children and the elderly in both underdeveloped and developed countries. Pathogenic S. flexneri strains possess a large virulence plasmid that codes for effector proteins that are required for the entry and spread of the bacteria into colonocytes. Among these proteins is the translocator IpaC, which plays an important role in the invasion process; IpaC is implicated in pore formation in the host cell membrane and induces cytoskeletal rearrangements in macrophages and epithelial cells, thereby promoting bacterial entry. The ability of IpaC to insert into the plasma membrane is due to a large nonpolar region of the protein structure. This characteristic also renders difficulties in recovery and purification when the protein is expressed in E. coli. Several works have considered different methodologies for the improved production and purification of IpaC. Herein, we propose an alternative method that is based on changes in the induction temperature and extraction buffer to facilitate the accumulation of high yields of soluble proteins for their further processing and ultimate use in biotechnological approaches.
Export Options
About this article
Cite this article as:
Mobilon Cristiane, Augusto Szymanski de Toledo Marcelo, Laroza Paganelli Fernanda, Aparecido dos Santos Clelton, de Pace Fernanda, Boldrin de Paiva Jacqueline, Guedes Stehling Eliana, Nakazato Gerson, Gambaro Balieiro Aline, Pereira da Silva Airoldi Flavia, de Assis Machado Reis Francisco and Dias da Silveira Wanderley, Cloning and Purification of IpaC Antigen from Shigella flexneri: Proposal of a New Methodology, Protein & Peptide Letters 2013; 20 (2) . https://dx.doi.org/10.2174/0929866511320020003
DOI https://dx.doi.org/10.2174/0929866511320020003 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biodiversity and Chemodiversity: Future Perspectives in Bioprospecting
Current Drug Targets AAV Hybrid Serotypes: Improved Vectors for Gene Delivery
Current Gene Therapy The Heat Stress Response and Diabetes: More Room for Mitochondrial Implication
Current Pharmaceutical Design Why and how do Microbubbles Enhance the Effectiveness of Diagnostic and Therapeutic Interventions in Cerebrovascular Disease?
Current Pharmaceutical Design Current Management of Neonatal Liver Tumors
Current Pediatric Reviews Benefits of L-Arginine on Cardiovascular System
Mini-Reviews in Medicinal Chemistry Reactive Oxygen Species and Antioxidants in the Pathophysiology of Cardiovascular Disease: Does the Actual Knowledge Justify a Clinical Approach?
Current Vascular Pharmacology Galectins: Major Signaling Modulators Inside and Outside the Cell
Current Molecular Medicine Sirtuins as Possible Drug Targets in Type 2 Diabetes
Current Drug Targets Does Parkinson’s Disease and Type-2 Diabetes Mellitus Present Common Pathophysiological Mechanisms and Treatments?
CNS & Neurological Disorders - Drug Targets Salusins in Hypertension and Related Cardiovascular Diseases
Current Drug Metabolism Inhibitors of Nitrogen Oxide Species Production in Animal Models of Inflammation and Future Directions for Therapy in Inflammatory Disorders
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Serotonin 5-HT<sub>1A</sub> Receptors and Antipsychotics - An Update in Light of New Concepts and Drugs
Current Pharmaceutical Design Gene Therapy to Improve High-Density Lipoprotein Metabolism and Function
Current Pharmaceutical Design p38 MAPK: A Potential Target of Chronic Pain
Current Medicinal Chemistry Effects of High Altitude Exposure on Physiology and Pharmacokinetics
Current Drug Metabolism Probing Heterotrimeric G Protein Activation: Applications to Biased Ligands
Current Pharmaceutical Design Pulmonary Arterial Hypertension
Current Vascular Pharmacology Surgical Management of Heart Failure
Current Cardiology Reviews Peripartum Cardiomyopathy: An Intensivist's Perspective
Current Women`s Health Reviews